{"data":{"id":"us-nj/n.j.-stat.-45-1-47","jurisdiction":"us-nj","citation":"N.J. Stat. § 45:1-47","heading":"Prescription monitoring program; provisions for expansion.","body":"27.\tPrescription Monitoring Program; provisions for expansion.\na.\tNotwithstanding the provisions of section 25 of P.L.2007, c.244 (C.45:1-45) to the contrary, the director may adopt a regulation to expand the program to require pharmacies to include information about each prescription dispensed for a prescription drug that is not a controlled dangerous substance.  In determining whether pharmacies should be required to submit to the program information about a prescription drug other than a controlled dangerous substance, the director shall consider: the actual or relative potential for abuse; scientific evidence of its pharmacological effect, if known; the state of current scientific knowledge regarding the drug; its history and current pattern of abuse, including its use to potentiate or enhance the effects of controlled dangerous substances that are subject to abuse; the scope, duration and significance of abuse; what, if any, risk to the public health; and its psychic or physiological dependence liability.\nb.\tAt the time the notice to expand the program pursuant to subsection a. is published in the New Jersey Register, the director shall provide a copy of the notice of proposed rule making to the chairpersons of the standing legislative reference committees on health of the Senate and General Assembly.\nL.2007, c.244, s.27; amended 2017, c.341, s.5.","path":["TITLE 45 PROFESSIONS AND OCCUPATIONS"],"source_url":"https://pub.njleg.state.nj.us/statutes/STATUTES-TEXT.zip","current_through":"P.L.2025, c.405, and J.R.22","vintage":"","retrieved_at":"2026-08-27T17:54:13Z","sha256":"f85a8409f101c86890bfb1e57194e04e24e01eecf12f14c712448ae33eb160ad","source_id":"us-nj","stale":true,"prev":"us-nj/n.j.-stat.-45-1-46.1","next":"us-nj/n.j.-stat.-45-1-48"},"notice":"GroundRules: Original legal text. Not legal advice."}